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Summary
We present the case of a thirty-year-old female patient who was referred to the endocrinology team with an enlarging 
goitre and biochemical hypothyroidism. She had been dependent on total parenteral nutrition for the previous six years 
as a result of intestinal failure thought to be caused by possible underlying mitochondrial disease. The patient also suffers 
from a Desmin myopathy, and at present, the exact aetiology behind her intestinal failure is not certain. The goitre was 
smooth and had been enlarging slowly over the previous few months. Thyroid peroxidase antibodies were found to 
be within normal range. Further analysis of the case showed that twelve months earlier the patients total parenteral 
nutrition (TPN) feed had been altered as a result of manganese toxicity. The current feeding regimen did not contain a 
trace element additive which had previously supplied iodine supplementation. A little detective work established that 
iodine content to the TPN had been reduced, the trace element additive (Additrace) was recommenced providing 1 µmol 
of iodine per day, equating to 130 µg of iodine. Following this change, thyroid-stimulating hormone levels returned to 
normal and the goitre quickly reduced in size. We present a rare case of endemic goitre and hypothyroidism in a patient 
receiving inadequate iodine supplementation through total parenteral nutrition.
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•	 Endemic goitre and hypothyroidism secondary to iodine deficiency are rare in the developed world. However, the 
diagnosis should be considered in the setting of a diffuse goitre and negative thyroid antibodies.
•	 Although rare, endemic goitre should be considered in patients who present with hypothyroidism and who are 
dependent on total parenteral nutrition.
•	 Treatment with levothyroxine is not required in endemic goitre as thyroid function tests generally normalise with 
the addition of iodine to the diet/total parenteral nutrition regimen.
•	 Iodine supplementation at a level recommended by the European Society for Clinical Nutrition and Metabolism 
(ESPEN) was observed to quickly normalise this patient’s thyroid function tests.
Background
Here we present a very rare presentation of a common 
disease. Autoimmune hypothyroidism is widespread 
both in primary care and within the hospital setting, 
and its investigation and management is well recognised. 
With the exclusion of iatrogenic causes (thyroidectomy, 
radiation), other causes of hypothyroidism are uncommon 
and are generally looked after by endocrine specialists.
Iodine deficiency in the developing world is the 
leading cause of hypothyroidism but is rarely encountered 
in developed countries due to adequate nutrition and 
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enrichment of foodstuffs with iodine salts. Our patient 
was unable to tolerate oral intake and was therefore 
entirely dependent on total parenteral nutrition (TPN) 
to meet her nutritional requirements. These patients are 
at risk of developing nutritional deficiencies culminating 
in clinically relevant disease where deficiencies occur as 
illustrated in this case.
Case presentation
We present the case of a thirty-year-old Caucasian female. 
The initial presentation was with the development of a 
rapidly enlarging goitre, which was noted by the patient’s 
primary care physician. This had been progressively 
increasing in size for the previous ten months. The 
patient described symptoms of fatigue and weight gain 
and was found to have biochemical hypothyroidism. On 
assessment, there was a large smooth goitre which was 
clinically larger on the right side. There were no other 
overt signs of hypothyroidism on examination.
The patient’s past medical history is complex. 
She developed intestinal failure in her early twenties 
and quickly became dependent on TPN. A diagnosis 
of Desmin myopathy has been made, but she is 
undergoing assessment at the regional genetics centre as a 
mitochondrial disorder is suspected. She has small bowel 
dysmotility for which she has a venting percutaneous 
endoscopic gastroscopy in situ. Her other comorbidities 
include eosinophilic granulomatosis with polyangitis and 
urinary retention. The patient has been dependent on 
TPN for six years.
One year prior to presentation with goitre and 
other features of hypothyroidism, a change was made 
to her TPN feeding regimen. This was necessitated by 
the development of manganese toxicity and led to the 
withdrawal of a trace element supplement, Additrace.
Investigation
Initial thyroid function tests showed thyroid-stimulating 
hormone (TSH) of 8.2 IU/L (0.2–4.2) and free T4 of 
5.9 pmol/L (11.0–22.0). These were subsequently repeated 
along with thyroid peroxidase antibodies (TPO) showing 
TSH of 8.3 IU/L and T4 of 6.1 pmol/L along with a TPO titre 
of <28 IU/mL. Five months later, the TSH had increased to 
25.0 IU/L and free T4 was 3.1 pmol/L. A total T3 level was 
checked at this point, which was within normal range at 
2.3 (0.9–2.5) nmol/L.
A diagnosis of iodine deficiency was considered, and 
the patient’s feeding regimen was altered to include trace 
element supplementation which contained iodine at the 
recommended amount. Subsequent thyroid function 
tests after four months showed TSH 0.65 IU/L, free T4 
10.0 pmol/L and total T3 2.1 nmol/L.
Treatment
Following the findings of increasing TSH and a normal 
thyroid peroxidase antibody level, the patient was 
recommenced on Additrace, an additive containing trace 
elements including iodine. This was given with the TPN 
feed. The patient had been receiving this up until one year 
prior to the development of the goitre, but biochemical 
evidence of manganese excess had necessitated it being 
stopped. Prior to this change, it was confirmed she was no 
longer suffering from manganese toxicity.
Additrace contains 16.6 µg of potassium iodide per 
mL as per its summary of product characteristics. The 
patient was commenced on 10 mL of Additrace per day. 
This equates to 130 µg of iodine in the 10 mL of Additrace 
received over a twenty-four hour period.
Prior to it being stopped due to manganese excess, the 
patient was receiving a lower dose of 5 mL Additrace per 
day, despite which she had never experienced symptoms 
of thyroid dysfunction.
Outcome and follow-up
The patient attends the nutrition clinic regularly and 
has regular follow-up by consultant gastroenterologist. 
She has unfortunately had a number of recent hospital 
admissions due to unrelated problems, but thyroid 
function tests have remained normal. She is due follow 
up in the endocrine outpatients department as previous 
appointments have had to be arranged due to illness.
Discussion
Cases of hypothyroidism in adults dependent upon TPN 
are rare in the literature. However, there are a number of 
cases reported in children.
One prospective study examining the urinary iodine 
concentration of children from the onset of TPN found 
there to be a significant decrease in urinary iodine levels 
as time progressed (1). Although in this small study none 
of the patients developed biochemical hypothyroidism, 
follow-up was limited to twelve weeks, and it is possible 
that this would have subsequently developed. Cases of 
severe hypothyroidism have been reported in children on 
TPN that have been successfully treated with parenteral 
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iodine supplementation (2). Our case highlights that 
adults with similar problems can successfully be treated 
in the same manner.
Published guidelines by the European Society for 
Clinical Nutrition and Metabolism (ESPEN) outline 
what is considered adequate iodine supplementation 
for patients receiving total parenteral nutrition (3). The 
recommendation is that adult patients should receive 
70–150 µg per day of iodine as part of their total parenteral 
nutrition regimen. Our patient was therefore started on 
what is deemed to be adequate iodine supplementation 
as she now receives 130 µg of iodine over a twenty-four 
hour period.
Interestingly, one study of patients on TPN found that 
only 26% of patients receiving iodine supplementation 
deemed adequate by ESPEN, with 19% of patients 
receiving iodine intake lower than that recommended, 
and 55% receiving no significant iodine intake at all (4). 
Across the whole population of that study, TSH was found 
to be elevated in 23% of patients with patients from 
both groups (those with adequate iodine replacement 
and those without) being represented. It would therefore 
appear that what can be considered as adequate intake 
of iodine to normalise thyroid function is variable 
between individuals.
The authors would urge other clinicians to consider 
iodine deficiency as a plausible diagnosis in patients 
dependent on artificial nutrition who present with a 
diffuse goitre and biochemical hypothyroidism.
Patient’s perspective
Unfortunately, the patient has had a number of complications with her 
TPN feeding in recent months with admissions to hospital. However, she 
feels her goitre has decreased in size, and there have been no further 
complications related to her hypothyroidism.
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